share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON KIMBERLY H

SEC announcement ·  Mar 20 04:23
Summary by Futu AI
On March 18, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $762.66 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,614 shares. The transaction, which was conducted in USD, is classified as a 'Grant, award or other acquisition' according to the transaction code description. This financial activity reflects a continued investment in the company by Johnson and may be of interest to current and potential investors.
On March 18, 2024, Kimberly H. Johnson, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock. The transaction involved the acquisition of 13 shares at a price of $762.66 per share. Following this transaction, Johnson's direct holdings in Eli Lilly and Co increased to a total of 2,614 shares. The transaction, which was conducted in USD, is classified as a 'Grant, award or other acquisition' according to the transaction code description. This financial activity reflects a continued investment in the company by Johnson and may be of interest to current and potential investors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.